Precision Biosciences (DTIL) Long-Term Investments (2021 - 2026)

Precision Biosciences (DTIL) has 6 years of Long-Term Investments data on file, last reported at $744000.0 in Q1 2026.

• Long-Term Investments for Q1 2026 came in at $744000.0, down 76.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $744000.0 (down 76.79% YoY), and the FY2025 annual result was $744000.0, down 76.79% from the prior year.
• Long-Term Investments steadied at $744000.0 in Q1 2026 per DTIL's latest filing, from $744000.0 in the prior quarter.
• Over five years, Long-Term Investments peaked at $3.2 million in Q4 2023 and troughed at $744000.0 in Q2 2025.
• A 5-year average of $2.2 million and a median of $2.6 million in 2022 frame the typical range for Long-Term Investments.
• The sharpest annual moves came in 2022 and 2025: Long-Term Investments surged 280.67% in 2022, then sank 76.79% in 2025.
• A 5-year view of Long-Term Investments shows it stood at $2.6 million in 2022, then grew by 24.46% to $3.2 million in 2023, then changed by 0.0% to $3.2 million in 2024, then slumped by 76.79% to $744000.0 in 2025, then changed by 0.0% to $744000.0 in 2026.
• Business Quant data shows DTIL's Long-Term Investments at $744000.0 in Q1 2026, $744000.0 in Q4 2025, and $744000.0 in Q3 2025.